中国卫生政策研究
中國衛生政策研究
중국위생정책연구
Chinese Journal of Health Policy
2015年
8期
44-50
,共7页
杨男%田燕%宋浩伟%宋民宪%彭亮%胡明
楊男%田燕%宋浩偉%宋民憲%彭亮%鬍明
양남%전연%송호위%송민헌%팽량%호명
低价药品%药品中标价格%日均药品费用%基本药物%医保目录
低價藥品%藥品中標價格%日均藥品費用%基本藥物%醫保目錄
저개약품%약품중표개격%일균약품비용%기본약물%의보목록
Low-price medicine%The bidder price of medicine%Average daily medicine cost%The essential medicines%Medical insurance directory
目的::分析低价药品政策可能产生的影响及实施过程中存在的问题。方法:检索国家食品药品监督管理总局等相关网站,收集低价药品清单中相关药品说明书;计算全国各省2009年1月—2014年8月不同企业品种中标价格对应的最高日均药品费用、最低日均药品费用等指标。结果:(1)低价药品清单中包含533种通用名药品,和基本药物品种的重合率为51.59%;97.56%的低价药品种纳入国家医保目录。(2)不同企业生产的同种药品中标价格对应的最高日均药品费用和最低日均药品费用的差值为0.01元~30.96元;89.1%的西药品种剂型低于限价标准。(3)不同低价药品生产企业中标价的日均药品费用差为0.01元~19.35元;92.13%的中成药品种低于限价标准。讨论:低价药品清单纳入品种缺乏严谨论证;低价药品定价的合理性和效果尚需验证;低价药品价格管理政策与其他政策的衔接仍需明确。
目的::分析低價藥品政策可能產生的影響及實施過程中存在的問題。方法:檢索國傢食品藥品鑑督管理總跼等相關網站,收集低價藥品清單中相關藥品說明書;計算全國各省2009年1月—2014年8月不同企業品種中標價格對應的最高日均藥品費用、最低日均藥品費用等指標。結果:(1)低價藥品清單中包含533種通用名藥品,和基本藥物品種的重閤率為51.59%;97.56%的低價藥品種納入國傢醫保目錄。(2)不同企業生產的同種藥品中標價格對應的最高日均藥品費用和最低日均藥品費用的差值為0.01元~30.96元;89.1%的西藥品種劑型低于限價標準。(3)不同低價藥品生產企業中標價的日均藥品費用差為0.01元~19.35元;92.13%的中成藥品種低于限價標準。討論:低價藥品清單納入品種缺乏嚴謹論證;低價藥品定價的閤理性和效果尚需驗證;低價藥品價格管理政策與其他政策的銜接仍需明確。
목적::분석저개약품정책가능산생적영향급실시과정중존재적문제。방법:검색국가식품약품감독관리총국등상관망참,수집저개약품청단중상관약품설명서;계산전국각성2009년1월—2014년8월불동기업품충중표개격대응적최고일균약품비용、최저일균약품비용등지표。결과:(1)저개약품청단중포함533충통용명약품,화기본약물품충적중합솔위51.59%;97.56%적저개약품충납입국가의보목록。(2)불동기업생산적동충약품중표개격대응적최고일균약품비용화최저일균약품비용적차치위0.01원~30.96원;89.1%적서약품충제형저우한개표준。(3)불동저개약품생산기업중표개적일균약품비용차위0.01원~19.35원;92.13%적중성약품충저우한개표준。토론:저개약품청단납입품충결핍엄근론증;저개약품정개적합이성화효과상수험증;저개약품개격관리정책여기타정책적함접잉수명학。
Objective:This paper aims to analyze the related effects of the low price medicine policy, and prob-lems in the implementation process. Methods:To retrieve an official website of the state food and medicine supervi-sion and administration, collect the package supplements of the low-price medicines and analyze their varieties according to their situations, and calculate he highest and lowest average daily use indicators for the medicine, etc. from January 2009 to August 2014. Results:(1) The low-price medicine list contains 533 kinds of standard medi-cines, and the coincidence rate with the essential medicines list is 51. 59%. Results also show that 96. 82% of the low-price medicines are incorporated into the national medical insurance directory. ( 2 ) The daily medicine cost difference of the maximum and minimum bidder price to the same medicine produced by different manufacturers ran-ges from 0. 01 to 30. 96 Yuan with 94. 76% of the western medicine dosage constituting the existing price rise space. (3) The daily medicine cost difference ranges from 0. 01 to 19. 35 Yuan with 92. 13% of the proprietary Chinese medicine varieties constituting the existing price rise space. Discussions:The low-price medicine varieties lack in the strict proof, the fact of low pricing the medicine has a two-way effect, and the connection between the low-price medi-cine administration policy and other policies is unclear.